A double-blind randomized trial included 23 selected patients with a confirmed diagnosis of tubal pregnancy who met the inclusion criteria ( hemodynamic stability , initial serum - hCG concentration < 2,000 mIU/mL , declining titers of - hCG 48 h prior to treatment , visible tubal pregnancy on transvaginal ultrasound , a tubal mass < 5.0 cm and fertility desire ) .